AZN.UK 阿斯利康制药
未开盘 08-15 16:30:00 BST 延时
13,166.00
+264.00
+2.05%
最高
13,218.00
最低
12,966.00
成交量
90.02万
今开
12,980.00
昨收
12,902.00
日振幅
1.95%
总市值
20.41万亿
流通市值
20.34万亿
总股本
15.50亿
成交额
118.30亿
换手率
0.06%
流通股本
15.45亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
阿斯利康中国:中国国家药监局批准泰瑞沙联合化疗治疗肺癌
THOMSON REUTERS · 06-26
阿斯利康中国:中国国家药监局批准泰瑞沙联合化疗治疗肺癌
【中恒集团(600252.SH)子公司莱美药业收到奥美拉唑镁肠溶片药品注册证书】智通财经APP讯,中恒集团(600252.
智通财经 · 03-19
【中恒集团(600252.SH)子公司莱美药业收到奥美拉唑镁肠溶片药品注册证书】智通财经APP讯,中恒集团(600252.
暂无数据
公司概况
公司名称:
阿斯利康制药
所属市场:
LSE
上市日期:
--
主营业务:
阿斯利康股份有限公司于1992年6月17日根据1985年《公司法》在英格兰和威尔士注册成立。该公司是在1993年将Imperial化学工业公司的制药、农化和特种化学品业务分拆时成立的。1999年,公司出售了特种化学品业务。同样在1999年,该公司与瑞典Astra公司合并。2000年,该公司将农化业务分拆,并将其与诺华公司的同类业务合并,成立了一家新的公司Syngenta AG。2007年,集团收购了位于美国的生物制剂和疫苗企业MedImmune。2021年,集团收购了位于美国的罕见病企业Alexion。
发行价格:
--
{"stockData":{"symbol":"AZN.UK","market":"UK","secType":"STK","nameCN":"阿斯利康制药","latestPrice":13166,"timestamp":1723735800000,"preClose":12902,"halted":0,"volume":900244,"delay":15,"floatShares":1544845450,"shares":1550277001,"eps":319.99777,"marketStatus":"未开盘","marketStatusCode":0,"change":264,"latestTime":"08-15 16:30:00 BST 延时","open":12980,"high":13218,"low":12966,"amount":11830145762,"amplitude":0.019532,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":319.99777,"exchange":"LSE","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1723791600000},"adr":0,"adjPreClose":12902,"adrRate":0,"openAndCloseTimeList":[[1723705200000,1723735800000]],"volumeRatio":1.0409929031161287,"nameEN":"ASTRAZENECA PLC","tradeCurrency":"GBX","tradeService":"SETS","exchangeMarketSize":300},"requestUrl":"/m/hq/s/AZN.UK/tweets","defaultTab":"tweets","newsList":[{"id":"2446334739","title":"阿斯利康中国:中国国家药监局批准泰瑞沙联合化疗治疗肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2446334739","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446334739?lang=zh_cn&edition=full","pubTime":"2024-06-26 14:55","pubTimestamp":1719384922,"startTime":"0","endTime":"0","summary":"阿斯利康中国:中国国家药监局批准泰瑞沙联合化疗治疗肺癌","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240626:nL4T3IO0G1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_zh_live","symbols":["LU0496365809.HKD","LU0969580561.USD","LU0052756011.USD","LU0963555726.SGD","LU1291159041.SGD","LU1481599808.USD","LU0211328371.USD","LU0047473722.SGD","LU0949170772.SGD","LU0109394709.USD","IE00BFTCPJ56.SGD","LU0889565916.HKD","LU0011850046.USD","LU1814569148.SGD","LU0047473722.EUR","LU0640478417.SGD","LU2236285917.USD","LU1481600234.SGD","LU0526926950.USD","LU0792757196.USD","03165","LU0738911758.USD","LU0211327993.USD","LU0976567544.SGD","LU1989771016.USD","LU0972486137.USD","LU0171293334.USD","LU1496350502.SGD","LU1496350171.SGD","LU0114720955.EUR","LU0158827948.USD","LU0557290698.USD","AZN","LU0128525689.USD","LU0266013472.USD","LU0784384876.USD","LU1989772840.SGD","BK4568","LU1487256676.USD","IE0009355771.USD","LU0949170426.SGD","AZN.UK","LU1019632923.USD","LU1019634622.SGD","LU1267930813.SGD","LU0310799852.SGD","LU0211326839.USD","IE00BJJMRZ35.SGD","LU0889565080.SGD","IE0034235188.USD"],"gpt_icon":0},{"id":"2420248251","title":"【中恒集团(600252.SH)子公司莱美药业收到奥美拉唑镁肠溶片药品注册证书】智通财经APP讯,中恒集团(600252.","url":"https://stock-news.laohu8.com/highlight/detail?id=2420248251","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2420248251?lang=zh_cn&edition=full","pubTime":"2024-03-19 17:47","pubTimestamp":1710841651,"startTime":"0","endTime":"0","summary":null,"market":"uk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0889565080.SGD","LU0792757196.USD","LU0969580561.USD","AZN.UK","LU0122379950.USD","LU0784385840.USD","IE00BJJMRZ35.SGD","LU0757432116.USD","LU1989771016.USD","LU0957799991.USD","IE0002141913.USD","BK0239","IE00BJT1NW94.SGD","LU1989772840.SGD","LU2089284900.SGD","LU0211328371.USD","SG9999013999.USD","LU0047473722.SGD","LU0526926950.USD","SG9999001176.USD","LU1487256676.USD","BK0015","LU1989772923.USD","LU0784384876.USD","LU0882574055.USD","LU0047473722.EUR","LU2089283258.USD","LU2468319806.SGD","IE0034235188.USD","LU0114720955.EUR","LU1267930813.SGD","BK0077","03165","LU1481600234.SGD","300006","LU1496350171.SGD","LU1057294990.SGD","LU0972486137.USD","LU0661504455.SGD","LU1023059063.AUD","LU1481599808.USD","LU0310799852.SGD","LU0963555726.SGD","600252","BK0070","LU0171293334.USD","SG9999001176.SGD","BK5011","LU2023251221.USD","LU0211327993.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.astrazeneca.com","stockEarnings":[{"period":"1week","weight":0.0426},{"period":"1month","weight":0.0948},{"period":"3month","weight":0.0939},{"period":"6month","weight":0.3329},{"period":"1year","weight":0.2369},{"period":"ytd","weight":0.2693}],"compareEarnings":[{"period":"1week","weight":0.0283},{"period":"1month","weight":0.0292},{"period":"3month","weight":0.0014},{"period":"6month","weight":0.1084},{"period":"1year","weight":0.1769},{"period":"ytd","weight":0.1071}],"compareStock":{"symbol":"ISF.UK","name":"FTSE100 ETF"},"description":"阿斯利康股份有限公司于1992年6月17日根据1985年《公司法》在英格兰和威尔士注册成立。该公司是在1993年将Imperial化学工业公司的制药、农化和特种化学品业务分拆时成立的。1999年,公司出售了特种化学品业务。同样在1999年,该公司与瑞典Astra公司合并。2000年,该公司将农化业务分拆,并将其与诺华公司的同类业务合并,成立了一家新的公司Syngenta AG。2007年,集团收购了位于美国的生物制剂和疫苗企业MedImmune。2021年,集团收购了位于美国的罕见病企业Alexion。","yearOnYearQuotes":[{"month":1,"riseRate":0.451613,"avgChangeRate":-0.001616},{"month":2,"riseRate":0.354839,"avgChangeRate":-0.00963},{"month":3,"riseRate":0.580645,"avgChangeRate":0.031821},{"month":4,"riseRate":0.677419,"avgChangeRate":0.027019},{"month":5,"riseRate":0.580645,"avgChangeRate":0.008233},{"month":6,"riseRate":0.5,"avgChangeRate":0.020988},{"month":7,"riseRate":0.65625,"avgChangeRate":0.012358},{"month":8,"riseRate":0.4375,"avgChangeRate":0.009899},{"month":9,"riseRate":0.645161,"avgChangeRate":0.00477},{"month":10,"riseRate":0.548387,"avgChangeRate":0.010725},{"month":11,"riseRate":0.483871,"avgChangeRate":0.004605},{"month":12,"riseRate":0.580645,"avgChangeRate":0.007055}],"exchange":"LSE","name":"阿斯利康制药","nameEN":"ASTRAZENECA PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"阿斯利康制药(AZN.UK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供阿斯利康制药(AZN.UK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"阿斯利康制药,AZN.UK,阿斯利康制药股票,阿斯利康制药股票老虎,阿斯利康制药股票老虎国际,阿斯利康制药行情,阿斯利康制药股票行情,阿斯利康制药股价,阿斯利康制药股市,阿斯利康制药股票价格,阿斯利康制药股票交易,阿斯利康制药股票购买,阿斯利康制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"阿斯利康制药(AZN.UK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供阿斯利康制药(AZN.UK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}